ARCHIVES

ASCO Foundation Raised $200,000 In Its First Year.

This article is from The Cancer Letter archive.

Vol. 26 No. 22 | June 2, 2000

Download PDF Visit The Full Archive

Related Articles

Letters: Alternatives Needs Scrutiny, Investigator Open-Mindedness

December 3, 1993

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

NCI Communications Office to contract Media Campaigns

October 22, 1993

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

October 23, 1992

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

October 25, 1985

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002